A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.
NFX
Activity from announced rounds
- Rounds participated in
- 12
- Confirmed lead rounds
- — 12 roles undisclosed
- New companies
- 11 First participation on record · 1 follow-on
- Funding in participating rounds
- $1.9B 12 disclosed · full round size, not this investor’s share
By stage
1 more
By primary sector
3 more
By country
Rounds
12 in this selectionBuilds orbital data centers running AI GPU compute in space
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
Builds universal infrastructure for cell engineering across drug discovery and cell therapy
LLM-agnostic agentic workflow platform for credit underwriting and portfolio monitoring in private markets
Autonomous software development platform that deploys thousands of AI agents to complete enterprise codebases
AI-powered learning platform making studying addictive
Develops neutral atom technology for scalable quantum computing
Provides autonomous cloud and AI infrastructure resource management platform
Builds orbital data centers running AI GPU compute in space
Builds a commission-free, peer-to-peer sports prediction market platform
Developing fully and rapidly reusable medium-lift launch vehicles